Related Experiment Videos

Protection against apoptosis by monoamine oxidase A inhibitors

W Malorni1, A M Giammarioli, P Matarrese

  • 1Department of Ultrastructures, Istituto Superiore di Sanità, Rome, Italy. Malorni@mclink.it

FEBS Letters
|May 23, 1998
PubMed

Insights

Monoamine oxidases (MAO) inhibitors like pargyline and clorgyline protect cells from apoptosis by maintaining mitochondrial homeostasis. Deprenyl, another MAO inhibitor, did not show this protective effect, highlighting the specific role of MAO-A inhibitors.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Neuroscience

Background:

  • Mitochondrial homeostasis is increasingly recognized as crucial in the early stages of apoptosis.
  • Monoamine oxidases (MAO) are enzymes involved in neurotransmitter metabolism, with implications in cellular processes.

Purpose of the Study:

  • To investigate the role of monoamine oxidases (MAO) inhibitors on mitochondrial integrity and apoptosis.
  • To determine if specific MAO inhibitors can protect cells from apoptosis.

Main Methods:

  • Utilized different monoamine oxidases (MAO) inhibitors: pargyline, clorgyline, and deprenyl.
  • Assessed the impact of these inhibitors on mitochondrial integrity and cellular apoptosis.
  • Induced apoptosis via serum starvation in cell models.

Main Results:

  • Pargyline and clorgyline demonstrated significant protection against serum starvation-induced apoptosis.
  • Deprenyl, a different MAO inhibitor, was ineffective in protecting cells from apoptosis.
  • MAO-A inhibitors (pargyline, clorgyline) appear to maintain mitochondrial homeostasis.

Conclusions:

  • MAO-A inhibitors offer cellular protection from apoptosis by preserving mitochondrial homeostasis.
  • This study provides the first evidence for MAO-A inhibitors mediating apoptosis protection through mitochondrial mechanisms.

Related Concept Videos